CW, D., J, W., Q, M., CL, C., BJ, K., B, L., . . . AR, G. (2025). Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients. Vaccine: X, 25, . https://doi.org/10.1016/j.jvacx.2025.100678
Chicago Style (17th ed.) CitationCW, Dukes, et al. "Neutralizing Antibody Response to SARS-CoV-2 Variants, as Determined by the MSD Multiplex Assay, Following COVID-19 Vaccination in Cancer Patients." Vaccine: X 25 (2025). https://doi.org/10.1016/j.jvacx.2025.100678.
MLA (9th ed.) CitationCW, Dukes, et al. "Neutralizing Antibody Response to SARS-CoV-2 Variants, as Determined by the MSD Multiplex Assay, Following COVID-19 Vaccination in Cancer Patients." Vaccine: X, vol. 25, 2025, https://doi.org/10.1016/j.jvacx.2025.100678.